Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTmt Investments Regulatory News (TMT)

Share Price Information for Tmt Investments (TMT)

Share Price is delayed by 15 minutes
Get Live Data
2.60    -0.04 (-1.57%)
Bid:
2.42
Ask:
2.60
Spread: 0.18 (7.438%)
Market Cap: $79.41m
TMT Live PriceLast checked at - London Stock Exchange

Intraday Tmt Investments Share Chart

Portfolio Update

1 Nov 2021 13:00

RNS Number : 9345Q
TMT Investments PLC
01 November 2021
 

1 November 2021

 

TMT INVESTMENTS PLC

("TMT" or the "Company")

 

Portfolio Update

 

TMT Investments Plc (AIM: TMT.L), the venture capital company investing in high-growth technology companies, notes the announcement released by 3D Systems (NYSE:DDD) on 27 October 2021 in respect of its agreement to acquire Volumetric Biotechnologies. Inc. ("Volumetric") (the "Acquisition"). According to the announcement released by 3D Systems, the Acquisition is to be structured as a US$45 million closing payment, with up to US$355 million of further consideration due on an earnout basis subject to the achievement of certain milestones linked to the attainment of significant steps in the demonstration of human applications (the "Contingent Consideration"), with all such payments comprising approximately half cash and half equity in 3D Systems. The Acquisition is expected to close in the fourth quarter of 2021.

 

TMT invested US$200,000 in Volumetric in July 2020 by way of a simple agreement for future equity ("SAFE") with a 20 per cent. discount on conversion subject to a valuation cap of US$12.5 million, which TMT expects will be converted and sold as part of the Acquisition.

 

The Company does not currently have any further information in relation to the milestones linked to the Contingent Consideration, and there can be no certainty that such milestones will ultimately be achieved.

 

 

For further information contact:

 

TMT Investments Plc

Alexander Selegenev

Executive Director

www.tmtinvestments.com

 

+44 (0)1534 281 800

(Computershare - Company Secretary)

 

alexander.selegenev@tmtinvestments.com

 

Strand Hanson Limited

(Nominated Adviser)

James Bellman / James Dance

 

+44 (0)20 7409 3494

Cenkos Securities plc

(Joint Broker)

Ben Jeynes

 

+44 (0)20 7397 8900

Hybridan LLP

(Joint Broker)

Claire Louise Noyce

 

+44 (0)20 3764 2341

Kinlan Communications

David Hothersall

 

+44 (0)20 7638 3435

davidh@kinlan.net

 

 

About TMT Investments Plc

 

TMT Investments Plc invests in high-growth technology companies across a number of core specialist sectors and has a significant number of Silicon Valley investments in its portfolio. Founded in 2010, TMT has a current investment portfolio of over 50 companies and net assets of US$218 million as of 30 June 2021. The Company's objective is to generate an attractive rate of return for shareholders, predominantly through capital appreciation. The Company is traded on the AIM market of the London Stock Exchange. www.tmtinvestments.com.

 

Twitter

 

LinkedIn

 

Facebook

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUUASURAKUARAA
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSLaunch of Share Buyback Programme
19th May 202612:14 pmRNSResult of Annual General Meeting
24th Mar 20267:00 amRNSFinal Results and Notice of AGM
19th Mar 20267:00 amRNSNotice of Final Results
24th Dec 20257:00 amRNSCompletion of Share Buyback Programme
23rd Dec 20257:00 amRNSHolding(s) in Company
23rd Dec 20257:00 amRNSHolding(s) in Company
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20258:16 amRNSPDMR Dealings
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20256:26 pmRNSPDMR Dealings
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20258:04 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSLaunch of Share Buyback Programme
21st Oct 202510:31 amRNSHoldings in Company
27th Aug 20255:00 pmRNSPDMR Dealings
12th Aug 20257:00 amRNSHalf-year Report
18th Jul 20251:45 pmRNSNotice of Interim Results
9th Jul 20257:00 amRNSPDMR Dealing
16th Jun 202511:54 amRNSPortfolio Update
20th May 20254:55 pmRNSResult of AGM
17th Apr 20252:45 pmRNSDirector Dealing
10th Apr 202512:00 pmRNSDirector Dealing
25th Mar 20257:00 amRNSFinal Results and Notice of AGM
20th Feb 20256:02 pmRNSDirector Dealing
10th Dec 20247:00 amRNSDirector Dealing
15th Aug 20247:00 amRNSHalf-year Report
6th Jun 20247:00 amRNSPortfolio Update
28th May 20245:10 pmRNSResult of AGM
9th May 202410:03 amRNSDirector Dealing
19th Mar 20247:00 amRNSFinal Results and Notice of AGM
28th Feb 20241:26 pmRNSHoldings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.